Skip to content

Does Finasteride Increase Size? A Pharmacological Review

4 min read

Finasteride is FDA-approved for treating male pattern hair loss and benign prostatic hyperplasia (BPH) [1.8.2]. The question of whether does finasteride increase size is complex, as it reduces prostate size but can, in rare cases, lead to breast tissue enlargement [1.3.5, 1.4.1].

Quick Summary

Finasteride's primary effect is shrinking the prostate gland in men with BPH. It does not increase penile size. A rare but noted side effect is gynecomastia, or the enlargement of male breast tissue.

Key Points

  • Prostate Size: Finasteride is proven to decrease the size of an enlarged prostate in patients with Benign Prostatic Hyperplasia (BPH) [1.3.4].

  • Penile Size: There is no credible scientific evidence that finasteride increases penis size; some anecdotal reports and animal studies suggest potential changes like numbness or perceived shrinkage [1.2.1, 1.7.2].

  • Breast Size: A rare side effect of finasteride is gynecomastia, which is the enlargement of male breast tissue [1.4.1, 1.4.4].

  • Mechanism of Action: The drug works by inhibiting the 5-alpha reductase enzyme, which significantly lowers levels of dihydrotestosterone (DHT) [1.5.1, 1.5.2].

  • Primary Uses: Finasteride is FDA-approved for treating male pattern hair loss (1 mg dose) and BPH (5 mg dose) [1.8.2].

  • Sexual Side Effects: Common adverse effects can include decreased libido, erectile dysfunction, and ejaculation disorders [1.9.5].

  • Post-Finasteride Syndrome (PFS): A condition where side effects persist long-term after stopping the medication, though it remains a complex and studied issue [1.7.1, 1.7.5].

In This Article

What is Finasteride and How Does It Work?

Finasteride is a medication classified as a 5-alpha reductase inhibitor [1.5.2]. Its primary mechanism of action is to block the enzyme 5-alpha reductase, specifically the type II isoenzyme [1.5.5]. This enzyme is responsible for converting testosterone into a more potent androgen called dihydrotestosterone (DHT) [1.5.2]. By inhibiting this process, finasteride can reduce circulating serum DHT levels by approximately 70% and prostatic DHT levels by over 90% [1.5.1].

DHT is a key hormone implicated in two common conditions in men:

  • Androgenetic Alopecia (Male Pattern Baldness): High levels of DHT at the scalp can cause hair follicles to shrink, leading to hair loss [1.5.5].
  • Benign Prostatic Hyperplasia (BPH): DHT stimulates the growth of the prostate gland [1.3.1].

Finasteride is FDA-approved to treat both of these conditions [1.8.2]. For hair loss (Propecia®), the typical dose is 1 mg daily, while for BPH (Proscar®), a 5 mg daily dose is used [1.2.1, 1.8.2].

The "Size" Question: Prostate, Penile, and Breast Tissue

The query "Does finasteride increase size?" requires looking at three different parts of the body, with three very different answers.

Prostate Size: A Decrease

For its approved indication in treating BPH, finasteride's goal is to decrease the size of an enlarged prostate [1.3.4]. By significantly lowering DHT levels within the prostate, the medication effectively shrinks the gland's volume [1.3.3, 1.3.6]. Studies have shown that finasteride can reduce prostate volume by at least 20% within the first year of treatment and that this effect is most beneficial for men with larger prostates (greater than 30 ml) [1.3.6, 1.3.2]. This size reduction helps alleviate urinary symptoms associated with BPH, such as weak stream and frequent urination, and can reduce the need for future prostate surgery [1.3.1]. The effect lasts only as long as the medication is taken; if discontinued, the prostate will begin to grow again [1.3.1].

Penile Size: No Evidence of Increase, Anecdotal Reports of Change

There is no clinical evidence to suggest that finasteride causes an increase in penis size [1.2.1]. The medication's mechanism of action on DHT does not support a growth effect on this tissue. However, some users have reported persistent sexual side effects, including a perception of penile numbness or even shrinkage [1.7.2]. A study on rat models did show that finasteride could reduce the weight of the corpus cavernosum and decrease the cross-sectional penile area [1.2.3, 1.2.2]. It's important to note that these are findings from animal studies and that direct physical shrinkage is not a recognized common side effect in human clinical trials [1.2.1].

Breast Size: Risk of Gynecomastia

A known, though uncommon, side effect of finasteride is gynecomastia—the enlargement of male breast tissue [1.9.1]. By altering the balance between androgens (like testosterone and DHT) and estrogen, finasteride can lead to breast tenderness and enlargement [1.4.5, 1.9.2]. The risk is dose-dependent and more common with the 5 mg dose used for BPH than the 1 mg dose for hair loss [1.4.6]. In one study, the incidence of gynecomastia was 2.2% in the finasteride group compared to 0.7% in the placebo group [1.4.4]. While rare, cases have been reported even with the low 1 mg dose, and this side effect may be underreported [1.4.1, 1.4.3]. If breast tissue changes, lumps, pain, or nipple discharge occur, it is critical to consult a doctor immediately [1.9.2].

Comparison Table: Finasteride vs. Dutasteride

Dutasteride is another 5-alpha reductase inhibitor, often compared to finasteride. It is more potent, inhibiting both type 1 and type 2 isoenzymes of 5-alpha reductase [1.6.1].

Feature Finasteride Dutasteride
Mechanism Inhibits Type 2 5-alpha reductase [1.5.5] Inhibits Type 1 & Type 2 5-alpha reductase [1.6.1]
Serum DHT Reduction ~70% [1.6.1] >90% [1.6.1]
FDA-Approved Uses BPH, Male Pattern Hair Loss [1.8.2] BPH [1.6.1]
Half-Life 6-8 hours [1.6.1] ~5 weeks [1.6.3]
Side Effect Profile Includes sexual dysfunction, gynecomastia [1.9.5] Similar to finasteride, though some studies note a higher incidence of decreased libido at higher doses [1.6.1]

Other Potential Side Effects and Considerations

Beyond changes in tissue size, finasteride is associated with other potential side effects. The most commonly reported are sexual in nature, including:

  • Decreased libido (sex drive) [1.9.2]
  • Erectile dysfunction [1.9.2]
  • Ejaculation disorders, including decreased semen volume [1.9.2]

These side effects occur in a small percentage of users (typically 2-4%) and often resolve after discontinuing the drug, though not always [1.9.5].

Post-Finasteride Syndrome (PFS) A controversial and serious consideration is Post-Finasteride Syndrome (PFS). This is a term used to describe a constellation of persistent sexual, neurological, physical, and psychological side effects that continue even after stopping the medication [1.7.1, 1.7.4]. Symptoms can include severe erectile dysfunction, depression, cognitive impairment ('brain fog'), anxiety, and penile shrinkage [1.7.1, 1.7.2]. The medical community is still working to understand the prevalence and mechanisms of PFS, but patients should be aware of this potential risk [1.7.4].

Conclusion

So, does finasteride increase size? The answer depends entirely on what tissue is in question.

  • It decreases prostate size, which is its therapeutic purpose for BPH [1.3.5].
  • It has no evidence of increasing penile size, with some reports of the opposite sensation [1.2.1].
  • It can increase breast size (gynecomastia) as a rare but significant side effect [1.4.1].

Finasteride is an effective medication for its approved uses, but its powerful hormonal effects come with a range of potential side effects. Anyone considering this medication should have a thorough discussion with their healthcare provider about the potential benefits and risks.


Authoritative Outbound Link: For more information on finasteride from a regulatory agency, visit the U.S. Food and Drug Administration's page on Propecia [1.8.1].

Frequently Asked Questions

Finasteride is FDA-approved for treating two conditions in men: androgenetic alopecia (male pattern hair loss) at a 1 mg dose, and benign prostatic hyperplasia (an enlarged prostate) at a 5 mg dose [1.8.2, 1.8.5].

Yes, one of the primary therapeutic effects of finasteride (at the 5 mg dosage) is to reduce the size of the prostate gland in men with BPH, which can improve urinary symptoms [1.3.4, 1.3.5].

Yes, finasteride can cause gynecomastia, which is the enlargement of male breast tissue. It is an uncommon side effect, occurring more frequently with the higher 5 mg dose used for BPH, but has been reported with the 1 mg dose as well [1.4.1, 1.4.4, 1.4.6].

There is no clinical evidence showing that finasteride increases penis size. Some anecdotal reports and information from Post-Finasteride Syndrome resources mention a sensation of numbness or perceived penile shrinkage, but this is not a common, proven side effect in major clinical trials [1.2.1, 1.7.2].

Finasteride works by blocking an enzyme called 5-alpha reductase. This prevents the conversion of testosterone to dihydrotestosterone (DHT), a hormone that causes prostate growth and hair loss in genetically susceptible men [1.5.2].

The most commonly reported sexual side effects include decreased libido (sex drive), erectile dysfunction, and problems with ejaculation, such as a reduced volume of semen. These affect a small percentage of users [1.9.2, 1.9.5].

Post-Finasteride Syndrome (PFS) is a condition where patients experience persistent sexual, neurological, and physical side effects (like erectile dysfunction, depression, and cognitive issues) that do not resolve after they have stopped taking the medication [1.7.1, 1.7.5].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.